← Back
Data updated: Mar 29, 2026
SCS
Cardiovascular
Generics
SCS is a generic drug manufacturer focused on Cardiovascular.
1992
Since
4
Drugs
-
Trials
53
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (1)
Discontinued (3)
Company Info
- First Approval
- 1992-05-29
- Latest
- 1994-03-25
- Applications
- 10